Advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing. Advancement in the field of molecular biology has equally enhanced the sequencing procedures. Many industry players have come up with innovative NGS technology in last few years.
DNA sequencing is the method used to determine the specific order of the four nucleotide bases, which form the DNA strand. DNA sequencing played a vital role during the mapping of the human genome, hence providing an important aspect for various basic as well as applied research. In recent days, DNA sequencing is being utilized in the field of pharmacogenomics. In recent years, there has been a decline in the prices of sequencing process, which has fuelled the growth of the DNA next generation sequencing market.
For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduces to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Major DNA next generation sequencing market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.
Get Sample report at https://www.theinsightpartners.com/sample/TIPRE00002934
The objective of the study is to describe, define, and forecast the DNA next generation sequencing market by product, application, end user, and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall DNA next generation sequencing market.
Next-generation sequencing (NGS), also known as high-throughput sequencing. NGS enables rapid sequencing of the base pairs in DNA samples. NGS is driving discovery and enabling the future of personalized medicine, genetic diseases, and clinical diagnostics. Key factors driving the growth of DNA next generation sequencing market are, increase in cancer prevalence, rise in funds and grants, focus of industry players and various meetings, conferences, workshops The report would be of an interest to various stakeholders operating in the DNA next generation sequencing market. These stakeholders include healthcare institutes, research institutes, infusion pumps product manufacturers and vendors, research consulting firms, service or product providers, distributors and others.
The market for DNA next generation sequencing is expected to grow significantly due to factors such as, declining price of sequencing, technological advancements in sequencing and increasing prevalence of cancer. In addition, usage of NSG in biomarker discovery & precision medicine is anticipated to have a positive impact on the growth of the DNA next generation sequencing market in the coming years.
Buy this Report now at https://www.theinsightpartners.com/buy/TIPRE00002934
Company Name: The Insight Partners
Contact Person: Sam J
Email: Send Email